Adefovir-dipivoxil

2021 ◽  
Vol 1881 (1) ◽  
pp. 19-19
Keyword(s):  
Adefovir Dipivoxil

scholarly journals rtE218G, a novel hepatitis B virus mutation with resistance to adefovir dipivoxil in patients with chronic hepatitis B

2010 ◽  
Vol 17 ◽  
pp. 66-72 ◽  
Author(s):  
L. J. Liu ◽  
J. H. Wang ◽  
S. C. Du ◽  
J. H. Tian ◽  
R. F. Yang ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Adefovir Dipivoxil ◽  
B Virus

Identification of novel adefovir dipivoxil-saccharin cocrystal polymorphs and their thermodynamic polymorphic transformations

2019 ◽  
Vol 566 ◽  
pp. 361-370 ◽  
Author(s):  
Kun Ma ◽  
Ningning Wang ◽  
Linfeng Cheng ◽  
Yuanfeng Wei ◽  
Jianjun Zhang ◽  
...  
Keyword(s):  
Adefovir Dipivoxil ◽  
Polymorphic Transformations

Ziprasidone Mesylate for Injection

2002 ◽  
Vol 37 (12) ◽  
pp. 1307-1317
Author(s):  
Dennis J. Cada ◽  
Terri Levien ◽  
Danial E. Baker
Keyword(s):  
Information Exchange ◽  
Hospital Pharmacy ◽  
Adefovir Dipivoxil ◽  
Late Phase ◽  
Phase Iii ◽  
Bulletin Board ◽  
Target Drug ◽  
Agalsidase Alfa ◽  
Phase Iii Trials ◽  
Drug Utilization Evaluation

Each month, subscribers to The Formulary Monograph Service receive five to six well-documented monographs on drugs that are newly released or are in late Phase III trials. The monographs are targeted to your Pharmacy and Therapeutics Committee. Subscribers also receive monthly one-page summary monographs on the agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation (DUE) is also provided each month. The monographs are published in printed form and on diskettes that allow customization. Subscribers to the The Formulary Monograph Service also receive access to a pharmacy bulletin board, The Formulary Information Exchange (The F.I.X.). All topics pertinent to clinical and hospital pharmacy are discussed on The F.I.X. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. If you would like information about The Formulary Monograph Service or The F.I.X., call The Formulary at 800–322–4349. The November 2002 monograph topics are adefovir dipivoxil, ximelagatran, agalsidase alfa and agalsidase beta, pemetrexed, and emtricitabine. The DUE is on adefovir dipivoxil.

M1908 Tenofovir Disoproxil Fumarate (TDF) for the Treatment of HBeAg-Negative Chronic Hepatitis B: Week 72 TDF Data and Week 24 Adefovir Dipivoxil Switch Data (Study 102)

2008 ◽  
Vol 134 (4) ◽  
pp. A-808 ◽  
Author(s):  
Patrick Marcellin ◽  
Ira M. Jacobson ◽  
Naoky Tsai ◽  
Natalie Bzowej ◽  
François Habersetzer ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Tenofovir Disoproxil Fumarate ◽  
Adefovir Dipivoxil ◽  
Negative Chronic Hepatitis

Adefovir-dipivoxil

2020 ◽  
Vol 1835 (1) ◽  
pp. 16-16
Keyword(s):  
Adefovir Dipivoxil
Sign in / Sign up

Export Citation Format

Share Document